HALO : Halozyme Therapeutics stock forecast, predictions, and share price target for 2021, 2022 (1 year) to 2025, 2026 (5 year) to 2030, and 2031 (10 year)

The 2 Wall Street analysts offering Halozyme Therapeutics stock forecast in the last 6 months have average price target of $55.0 with a high forecast of $60.0 and a low forecast of $50.0. The average Halozyme Therapeutics stock forecast represents a 28.59% increase from the last price of $42.77. From AI system, total return is 2022.2% from 1610 forecasts. For Halozyme Therapeutics stock forecast 2021, 8 predictions are offered for each month of 2021 with average Halozyme Therapeutics stock forecast of $39.84, a high forecast of $42.02, and a low forecast of $37.86. The average Halozyme Therapeutics stock forecast 2021 represents a -6.86% decrease from the last price of $42.77. For Halozyme Therapeutics stock forecast 2022, 12 predictions are offered for each month of 2022 with average Halozyme Therapeutics stock forecast of $35.81, a high forecast of $37.3, and a low forecast of $35.22. The average Halozyme Therapeutics stock forecast 2022 represents a -16.27% decrease from the last price of $42.77. For Halozyme Therapeutics stock forecast 2025, 12 predictions are offered for each month of 2025 with average Halozyme Therapeutics stock forecast of $41.11, a high forecast of $41.59, and a low forecast of $40.68. The average Halozyme Therapeutics stock forecast 2025 represents a -3.88% decrease from the last price of $42.77. For Halozyme Therapeutics stock forecast 2026 (5 year), 12 predictions are offered for each month of 2026 with average Halozyme Therapeutics stock forecast of $41.96, a high forecast of $42.18, and a low forecast of $41.62. The average Halozyme Therapeutics stock forecast 2026 represents a -1.89% decrease from the last price of $42.77. For Halozyme Therapeutics stock forecast 2030, 12 predictions are offered for each month of 2030 with average Halozyme Therapeutics stock forecast of $38.11, a high forecast of $39.81, and a low forecast of $36.6. The average Halozyme Therapeutics stock forecast 2030 represents a -10.89% decrease from the last price of $42.77. For Halozyme Therapeutics stock forecast 2031 (10 year), 4 predictions are offered for each month of 2031 with average Halozyme Therapeutics stock forecast of $35.73, a high forecast of $36.3, and a low forecast of $35.08. The average Halozyme Therapeutics stock forecast 2031 represents a -16.45% decrease from the last price of $42.77. Please, see more forecasts below.